Breaks Categories: Stock Spotlights

ThursdayApr 13, 2017 12:59 pm

NetworkNewsBreaks – Relmada Therapeutics, Inc.’s (RLMD) d-Methadone Receives Fast Track Designation by FDA; Shares Rise

Relmada Therapeutics’ (OTCQB: RLMD) shares are up 20% mid-day after the company said that it has received Fast Track designation for d-Methadone from the U.S. Food and Drug Administration (FDA) for the adjunctive treatment of major depressive disorder. This designation offers many advantages, including more frequent meetings and written communications with the FDA, accelerated review and priority approval, and rolling New Drug Application review. "The designation of Fast Track status by the FDA is further validation of the potential for d-Methadone to represent a major advance in treatment that can help patients with inadequate response to the current standard of…

Continue Reading

ThursdayApr 13, 2017 11:51 am

NetworkNewsBreaks – SeeThruEquity Issues Updated Coverage on GEE Group, Inc. (NYSE: JOB)

SeeThruEquity has issued an update on shares of GEE Group’s (NYSE: JOB) stock following recent first quarter 2017 financial results, in which the company reported revenues of $22 million, compared to $17.6 million in the first quarter of 2016. GEE Group also recently acquired SNI Companies, a private staffing company with over $100 million in annual revenue. The analyst cited this acquisition as fuel to accelerate the company’s penetration into professional staffing and generate cash flow. For more information visit www.geegroup.com About GEE Group Inc. GEE Group Inc. is a provider of specialized staffing solutions and is the successor to…

Continue Reading

WednesdayApr 12, 2017 12:06 pm

NetworkNewsBreaks – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) Schedules End of Phase 2 FDA Meeting, Initiates Phase 3 Development

Ritter Pharmaceuticals (NASDAQ: RTTR) shares are up 15% after the company said that the U.S. Food and Drug Administration (FDA) has agreed to an end of phase 2 meeting. The meeting is expected to take place in the third quarter of 2017 to discuss the results of Ritter’s recently completed phase 2b/3 trial, which demonstrated numerous positive topline results. A full analysis of the data is currently underway. The company also plans to discuss phase 3 plans in preparation of a New Drug Application (NDA) submission of RP-G28 for the treatment of lactose intolerance. "Based on the topline results of…

Continue Reading

TuesdayApr 11, 2017 11:47 am

NetworkNewsBreaks – Tonix Pharmaceuticals (NASDAQ: TNXP) Shares Rally on Results from U.S. FDA Meeting on TNX-102 SL for PTSD

Shares of Tonix Pharmaceuticals (NASDAQ: TNXP) are up 12% this morning on news that the company has received official minutes from its Initial Cross-Disciplinary Breakthrough Meeting held with the U.S. Food and Drug Administration (FDA) on March 9, 2017.  After being awarded Breakthrough Therapy designation in December 2016, Tonix was invited to meet with the FDA to evaluate the feasibility of accelerating the development and registration of TNX-102 SL for the treatment of posttraumatic stress disorder (PTSD). “The FDA’s standard of evidence for drug approval typically requires two positive Phase 3 trials; however, following our Initial Cross-Disciplinary Breakthrough Meeting in…

Continue Reading

MondayApr 10, 2017 12:53 pm

NetworkNewsBreaks – Cemtrex, Inc. (NASDAQ: CETX) Shares Climb on Multi-Million Dollar Purchase Order, Expectations for Organic Growth

Cemtrex (NASDAQ: CETX) this morning said it has received a multi-million dollar order from HBH GmbH of Germany to build electronic components for high-power HF amplifiers for the FRIB particle accelerator at Michigan State University. The company expects to complete the order for the new customer over the next 18-month period. “We are excited to be working with HBH GmbH in supporting Michigan State University on this unique application. We believe that working on extremely complex high-tech electronics such as this validates our underlying strategy to focus on niche high-value markets. This strategy is expected to allow us to maintain…

Continue Reading

MondayApr 10, 2017 12:50 pm

NetworkNewsBreaks – Geron Corp. (NASDAQ: GERN) Shares Higher on Second Internal Data Reviews for Imetelstat Trials

Geron Corporation (NASDAQ: GERN) shares climbed 21% on news that the second internal data reviews of the company’s IMerge and IMbark clinical trials have been completed by Janssen Research & Development, LLC. IMerge, the study of the telomerase inhibitor imetelstat in lower risk myelodysplastic syndromes (MDS), demonstrated that the benefit/risk profile of imetelstat in the treated patients supports continued development. The company intends to provide the FDA with a data package and proposed trial design refinements. For IMbark, a study of imetelstat in relapsed or refractory myelofibrosis (MF), current data suggest clinical benefit and a potential overall survival benefit. The…

Continue Reading

MondayApr 10, 2017 10:44 am

NetworkNewsBreaks – MGX Minerals, Inc. (MGXMF) Commences Unitization of Oil and Gas Leases in Utah’s Paradox Basin

Diversified mining company MGX Minerals, Inc. (OTC: MGXMF) this morning offered a project development update for its Paradox Basin petrolithium project. Notably, the company has begun unitization of designated oil and gas leases and the staking of overlying mineral claims located contiguous to its Lisbon Valley mineral claims. The purpose of these efforts is to eliminate existing property boundaries and pool mineral interests in order to establish MGX’s private partner as unit operator. Per the news release, consolidation of the oil and gas leases represents the most efficient timelines and cost-effective means of developing the area’s underlying resources. In total,…

Continue Reading

MondayApr 10, 2017 9:16 am

NetworkNewsBreaks – Singlepoint, Inc. (SING) Comments on Proposed Congressional Legislation to Regulate Marijuana

In March, Congress introduced legislation to regulate and tax marijuana, and to remove it from the federal Controlled Substances Act. SinglePoint, Inc. (OTC: SING) CEO Greg Lambrecht recently commented on how the proposed legislation could affect the company. SinglePoint has seen much revenue potential in the realm of legal cannabis, and hopes measures will be taken to streamline federal and state oversight of the market. Its interests go beyond investing. The congressional push should also help boost the value of its SingleSeed (www.SingleSeed.com) payments solutions for businesses in the cannabis industry. ‘For the near term, the best way the administration…

Continue Reading

FridayApr 07, 2017 12:56 pm

NetworkNewsBreaks – Yippy, Inc. (YIPI) Secures Compression Software and Technology Deal with Globalstar (NYSE: GSAT)

Shares of Yippy (OTC: YIPI) are up 9% on news that it will support Globalstar, Inc.'s (NYSE: GSAT) initiative to market its compression software and intranet data services. Yippy also noted that it recently completed production level environment for Globalstar's Generation 2 network, surpassing performance requirements. Yippy's software platform features advanced data compression technology that significantly decreases webpage load times for Internet access and intranet document retrieval. "Satellite bandwidth is a finite asset, and most satellite providers have an immediate need to reduce bandwidth overhead per subscriber across their networks. Our compression technology does just that, and is production ready…

Continue Reading

ThursdayApr 06, 2017 1:21 pm

NetworkNewsBreaks – MGX Minerals, Inc. (MGXMF) Develops Faster, Less Expensive Lithium Extraction Method

MGX Minerals (OTC: MGXMF) is set to tackle the growing lithium market with its new extraction technology capable of addressing environmental concerns along with the demand for lithium supply. “This innovative company is poised to ignite a revolution in the energy sector with technology that extracts lithium from oil and gas wells. Its PetroLithium™ methodology separates valuable minerals from the salt water that typically accompanies crude oil, offering a novel way to extract lithium, an essential ingredient in the batteries of our laptops, mobile phones, and other electronic devices and, increasingly, our cars. As MGX refines its technology, it is…

Continue Reading